BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

593 related articles for article (PubMed ID: 22992524)

  • 1. Compensatory dendritic cell development mediated by BATF-IRF interactions.
    Tussiwand R; Lee WL; Murphy TL; Mashayekhi M; KC W; Albring JC; Satpathy AT; Rotondo JA; Edelson BT; Kretzer NM; Wu X; Weiss LA; Glasmacher E; Li P; Liao W; Behnke M; Lam SS; Aurthur CT; Leonard WJ; Singh H; Stallings CL; Sibley LD; Schreiber RD; Murphy KM
    Nature; 2012 Oct; 490(7421):502-7. PubMed ID: 22992524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Batf3-dependent CD103+ dendritic cells are major producers of IL-12 that drive local Th1 immunity against Leishmania major infection in mice.
    Martínez-López M; Iborra S; Conde-Garrosa R; Sancho D
    Eur J Immunol; 2015 Jan; 45(1):119-29. PubMed ID: 25312824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BATF-JUN is critical for IRF4-mediated transcription in T cells.
    Li P; Spolski R; Liao W; Wang L; Murphy TL; Murphy KM; Leonard WJ
    Nature; 2012 Oct; 490(7421):543-6. PubMed ID: 22992523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peripheral CD103+ dendritic cells form a unified subset developmentally related to CD8alpha+ conventional dendritic cells.
    Edelson BT; KC W; Juang R; Kohyama M; Benoit LA; Klekotka PA; Moon C; Albring JC; Ise W; Michael DG; Bhattacharya D; Stappenbeck TS; Holtzman MJ; Sung SS; Murphy TL; Hildner K; Murphy KM
    J Exp Med; 2010 Apr; 207(4):823-36. PubMed ID: 20351058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.
    Grajales-Reyes GE; Iwata A; Albring J; Wu X; Tussiwand R; Kc W; Kretzer NM; Briseño CG; Durai V; Bagadia P; Haldar M; Schönheit J; Rosenbauer F; Murphy TL; Murphy KM
    Nat Immunol; 2015 Jul; 16(7):708-17. PubMed ID: 26054719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative profiling of BATF family proteins/JUNB/IRF hetero-trimers using Spec-seq.
    Chang YK; Zuo Z; Stormo GD
    BMC Mol Biol; 2018 Mar; 19(1):5. PubMed ID: 29587652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Batf3-dependent CD8α
    Li Y; Liu X; Duan W; Tian H; Zhu G; He H; Yao S; Yi S; Song W; Tang H
    EBioMedicine; 2017 Apr; 18():188-198. PubMed ID: 28411140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-12 from CD103
    Mittal D; Vijayan D; Putz EM; Aguilera AR; Markey KA; Straube J; Kazakoff S; Nutt SL; Takeda K; Hill GR; Waddell N; Smyth MJ
    Cancer Immunol Res; 2017 Dec; 5(12):1098-1108. PubMed ID: 29070650
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8α+ DCs can be induced in the absence of transcription factors Id2, Nfil3, and Batf3.
    Seillet C; Jackson JT; Markey KA; Brady HJ; Hill GR; Macdonald KP; Nutt SL; Belz GT
    Blood; 2013 Feb; 121(9):1574-83. PubMed ID: 23297132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NFIL3/E4BP4 is a key transcription factor for CD8α⁺ dendritic cell development.
    Kashiwada M; Pham NL; Pewe LL; Harty JT; Rothman PB
    Blood; 2011 Jun; 117(23):6193-7. PubMed ID: 21474667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Batf3-dependent CD11b(low/-) peripheral dendritic cells are GM-CSF-independent and are not required for Th cell priming after subcutaneous immunization.
    Edelson BT; Bradstreet TR; KC W; Hildner K; Herzog JW; Sim J; Russell JH; Murphy TL; Unanue ER; Murphy KM
    PLoS One; 2011; 6(10):e25660. PubMed ID: 22065991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8α
    Kline DE; MacNabb BW; Chen X; Chan WC; Fosco D; Kline J
    J Immunol; 2018 Dec; 201(12):3759-3769. PubMed ID: 30420437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Batf3 and Id2 have a synergistic effect on Irf8-directed classical CD8α+ dendritic cell development.
    Jaiswal H; Kaushik M; Sougrat R; Gupta M; Dey A; Verma R; Ozato K; Tailor P
    J Immunol; 2013 Dec; 191(12):5993-6001. PubMed ID: 24227775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BATF3 is sufficient for the induction of Il9 expression and can compensate for BATF during Th9 cell differentiation.
    Lee WH; Jang SW; Kim HS; Kim SH; Heo JI; Kim GE; Lee GR
    Exp Mol Med; 2019 Nov; 51(11):1-12. PubMed ID: 31776325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Batf3 deficiency reveals a critical role for CD8alpha+ dendritic cells in cytotoxic T cell immunity.
    Hildner K; Edelson BT; Purtha WE; Diamond M; Matsushita H; Kohyama M; Calderon B; Schraml BU; Unanue ER; Diamond MS; Schreiber RD; Murphy TL; Murphy KM
    Science; 2008 Nov; 322(5904):1097-100. PubMed ID: 19008445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD8α(+) dendritic cells are the critical source of interleukin-12 that controls acute infection by Toxoplasma gondii tachyzoites.
    Mashayekhi M; Sandau MM; Dunay IR; Frickel EM; Khan A; Goldszmid RS; Sher A; Ploegh HL; Murphy TL; Sibley LD; Murphy KM
    Immunity; 2011 Aug; 35(2):249-59. PubMed ID: 21867928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Batf3 selectively determines acquisition of CD8
    Chandra J; Kuo PT; Hahn AM; Belz GT; Frazer IH
    Immunol Cell Biol; 2017 Feb; 95(2):215-223. PubMed ID: 27897162
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
    Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Migratory CD103+ dendritic cells suppress helminth-driven type 2 immunity through constitutive expression of IL-12.
    Everts B; Tussiwand R; Dreesen L; Fairfax KC; Huang SC; Smith AM; O'Neill CM; Lam WY; Edelson BT; Urban JF; Murphy KM; Pearce EJ
    J Exp Med; 2016 Jan; 213(1):35-51. PubMed ID: 26712805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity through cooperation: BATF-IRF interactions control immune-regulatory networks.
    Murphy TL; Tussiwand R; Murphy KM
    Nat Rev Immunol; 2013 Jul; 13(7):499-509. PubMed ID: 23787991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.